Article Figures & Data
Tables
Region Group n Mean SD 95% CI Lumbar spine Control 38 1.029 0.131 0.986–1.072 EIAEDs 72 0.906* 0.203 0.858–0.954 Non-EIAEDs 36 0.905* 0.215 0.832–0.977 Ward triangle Control 38 0.873 0.254 0.79–0.957 EIAEDs 72 0.776 0.344 0.695–0.856 Non-EIAEDs 36 0.772 0.375 0.645–0.899 Greater trochanter Control 38 0.729 0.119 0.690–0.769 EIAEDs 72 0.682 0.134 0.651–0.714 Non-EIAEDs 36 0.722 0.143 0.674–0.771 Femoral neck Control 38 1.004 0.102 0.971–1.038 EIAEDs 72 0.922* 0.161 0.884–0.96 Non-EIAEDs 36 0.946 0.164 0.890–1.001 Total hip Control 38 0.869 0.141 0.822–0.915 EIAEDs 72 0.793 0.184 0.75–0.837 Non-EIAEDs 36 0.813 0.203 0.745–0.882 ↵* P < 0.05, compared with control.
CI = confidence interval.
Region Therapy n Mean SD 95% CI Lumbar spine Polytherapy 52 0.933 0.188 0.881–0.985 Carbamazepine monotherapy 33 0.848* 0.213 0.772–0.924 Valproate monotherapy 22 0.917 0.231 0.814–1.019 Control 38 1.0289 0.131 0.986–1.072 Ward triangle Polytherapy 52 0.792 0.307 0.706–0.877 Carbamazepine monotherapy 33 0.744 0.394 0.604–0.884 Valproate monotherapy 22 0.781 0.407 0.601–0.962 Control 38 0.873 0.254 0.79–0.957 Greater trochanter Polytherapy 52 0.708 0.140 0.669–0.747 Carbamazepine monotherapy 33 0.656 0.134 0.608–0.703 Valproate monotherapy 22 0.731 0.133 0.671–0.79 Control 38 0.729 0.119 0.69–0.769 Femoral neck Polytherapy 52 0.938 0.1507 0.896–0.98 Carbamazepine monotherapy 33 0.887** 0.174 0.825–0.949 Valproate monotherapy 22 0.974 0.163 0.901–1.046 Control 38 1.004 0.102 0.971–1.038 Total hip Polytherapy 52 0.813 0.161 0.768–0.857 Carbamazepine monotherapy 33 0.762 0.213 0.686–0.838 Valproate monotherapy 22 0.828 0.217 0.732–0.925 Control 38 0.869 0.141 0.823–0.915 ↵* P < 0.01 compared with control.
CI = confidence interval.
